Instil Bio, Inc. (TIL) stock
TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.43+0.03 (+0.56%)
Close on Nov 18, 2026Market cap $36.83MP/E –Yield –
Instil Bio free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Instil Bio's free cash flow for the twelve months ending Dec 31, 2024 was -$55.70M. For fiscal 2024 it was -$55.70M. The highest annual figure on record is -$55.70M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$55.70M | – |
| FY2023 | Dec 31, 2023 | -$102.69M | – |
| FY2022 | Dec 31, 2022 | -$264.75M | – |
| FY2021 | Dec 31, 2021 | -$179.97M | – |
| FY2020 | Dec 31, 2020 | -$80.43M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$10.56M | – |
| Q3 FY2024 | Sep 30, 2024 | -$20.13M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.61M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.39M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.44M | – |
| Q3 FY2023 | Sep 30, 2023 | -$19.58M | – |
| Q2 FY2023 | Jun 30, 2023 | -$26.54M | – |
| Q1 FY2023 | Mar 31, 2023 | -$43.13M | – |
| Q4 FY2022 | Dec 31, 2022 | -$49.99M | – |
| Q3 FY2022 | Sep 30, 2022 | -$66.08M | – |
| Q2 FY2022 | Jun 30, 2022 | -$73.40M | – |
| Q1 FY2022 | Mar 31, 2022 | -$75.29M | – |
| Q4 FY2021 | Dec 31, 2021 | -$61.25M | – |
| Q3 FY2021 | Sep 30, 2021 | -$51.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$40.72M | – |
| Q1 FY2021 | Mar 31, 2021 | -$26.86M | – |
| Q4 FY2020 | Dec 31, 2020 | -$62.09M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.54M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.55M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.25M | – |
See a number that looks wrong?